Polar Asset Management Partners’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-246,650
Closed -$158K 1540
2021
Q2
$158K Sell
246,650
-119,318
-33% -$85.5K ﹤0.01% 970
2021
Q1
$344K Sell
365,968
-142,843
-28% -$158K ﹤0.01% 655
2020
Q4
$504K Sell
508,811
-23,689
-4% -$17.9K 0.01% 548
2020
Q3
$383K Buy
+532,500
New +$372K 0.01% 452

Polar Asset Management Partners's CHAQ.WS Position: Q3 2021 in Review

Polar Asset Management Partners sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 246,650 shares — an estimated $158K sold.

Polar Asset Management Partners first reported a position in CHAQ.WS in Q3 2020 and held it in 4 quarters. The position peaked at $504K in Q4 2020. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

  • Polar Asset Management Partners reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
  • Polar Asset Management Partners sold 246,650 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $158K.
  • Polar Asset Management Partners first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q3 2020 and held it in 4 quarters.
  • Polar Asset Management Partners's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $504K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on Polar Asset Management Partners's 13F filing for Q3 2021, filed 15 Nov 2021.